Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BRD4 profiling identifies critical Chronic Lymphocytic Leukemia oncogenic circuits and reveals sensitivity to PLX51107, a novel structurally distinct BET inhibitor
PubMed Full text in PMC Similar studies Analyze with GEO2R
BRD4 profiling identifies critical Chronic Lymphocytic Leukemia oncogenic circuits and reveals sensitivity to PLX51107, a novel structurally distinct BET inhibitor [expression profiling]
BRD4 profiling identifies critical Chronic Lymphocytic Leukemia oncogenic circuits and reveals sensitivity to PLX51107, a novel structurally distinct BET inhibitor [ChIP-seq]
PubMed Full text in PMC Similar studies SRA Run Selector
Transcriptional changes induced by Brd4 inhibitor, AZD5153, in cancer cell lines
PubMed Similar studies Analyze with GEO2RSRA Run Selector
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability
PubMed Similar studies
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq)
PubMed Similar studies SRA Run Selector
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq)
HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia
PubMed Full text in PMC Similar studies
HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia [miRNA-seq]
HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia [RNA-seq]
HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia [ChIP-seq]
Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
BET inhibition reforms the immune microenvironment and alleviates T-cell dysfunction in chronic lymphocytic leukemia
Identification of HOXB13 target genes responsive to BET inhibitors
Gene Expression Analysis of metastatic CRPC cell line C4-2B treated with the dual BET-kinase inhibitor MA4-022-1
Effects of BRD4 inhibition in AML
PubMed Similar studies Analyze with GEO2R
Enhancer profiling of chronic lymphocytic leukemia cells
Response and resistance to BET bromodomain inhibitors in triple negative breast cancer
Response and resistance to BET bromodomain inhibitors in triple negative breast cancer [RNA-Seq]
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on